Renal Cancer
Renal cell carcinoma: entering the age of biomarkers.
September 4, 2024
Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.
September 4, 2024
Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus.
September 2, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in peripheral blood predict nivolumab response in patients with metastatic renal cell cancer.
September 2, 2024
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer.
August 30, 2024
Renal Cell Carcinoma A Review
August 28, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.
August 28, 2024
APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression.
August 28, 2024
The influence of sex hormones on renal cell carcinoma.
August 26, 2024
Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma.
August 26, 2024
Exploring the Feasibility of GPT-4 as a Data Extraction Tool for Renal Surgery Operative Notes.
August 26, 2024
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau".
August 26, 2024